Suppr超能文献

硫利达嗪和三氟拉嗪用于急性精神错乱的精神分裂症患者。

Thiothixene and trifluoperazine in acutely disturbed schizophrenic patients.

作者信息

Ahmad S H, Hasan K Z

出版信息

J Pak Med Assoc. 1977 Apr;27(4):313-6.

PMID:411951
Abstract

In acutely disturbed newly admitted patients at Neuropsychiatric Unit, Karachi, the efficacy of thiothixene is not significantly different as compared to trifluoperazine. In trifluoperazine group also all the target symptoms improved while 'depressive mood' and 'suspiciousness' did not change significantly. In thiothixene group significant improvement was noticed on all the target symptoms except 'tension' and 'depressive mood'. The ethnic or genetic make up of the patient population was concluded to be the reason for non-effectiveness of thisthixene on effective psychopathology in acute schizophrenia. The extra-pyramidal side effects were clinically more pronounced in thiothixene group.

摘要

在卡拉奇神经精神科新收治的急性精神障碍患者中,硫利达嗪的疗效与三氟拉嗪相比无显著差异。在三氟拉嗪组中,所有目标症状均有改善,但“抑郁情绪”和“猜疑”无显著变化。在硫利达嗪组中,除“紧张”和“抑郁情绪”外,所有目标症状均有显著改善。得出结论,患者群体的种族或基因构成是硫利达嗪对急性精神分裂症有效精神病理学无效的原因。硫利达嗪组的锥体外系副作用在临床上更为明显。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验